BioCentury
ARTICLE | Financial News

Nektar completes follow-on

October 24, 2016 7:00 AM UTC

Nektar Therapeutics (NASDAQ:NKTR), San Francisco, Calif.Business: Cancer, Neurology, InfectiousDate completed: 2016-10-18Type: Follow-onRaised: $175.5 millionShares: 13 millionPrice: $13.50Shares afte...